Get started
Author

Anna Shteingauz

Observed names: A Shteingauz, A. Shteingauz, Anna Shteingauz2, Shteingauz, Anna
OpenAlex ID: A5034223483
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells
2015 · Moshe Giladi, Rosa S Schneiderman, et al. · Scientific Reports · 338
PDF
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
2020 · Tali Voloshin, Noa Kaynan, et al. · Cancer Immunology Immunotherapy · 185
PDF
Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy
2015 · Anna Shteingauz, Ilanit Boyango, et al. · Cancer Research · 156
Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity
2010 · Flonia Levy-Adam, Sari Feld, et al. · Journal of Biological Chemistry · 145
AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)
2018 · Anna Shteingauz, Yaara Porat, et al. · Cell Death and Disease · 109
PDF
Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo
2016 · Tali Voloshin, Mijal Munster, et al. · International Journal of Cancer · 81
PDF
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
2017 · Yaara Porat, Moshe Giladi, et al. · Journal of Visualized Experiments · 68
PDF
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models
2021 · Helena Mumblat, Antonia Martinez-Conde, et al. · Lung Cancer · 53
Function from within: Autophagy induction by HPSE/heparanase—new possibilities for intervention
2015 · Neta Ilan, Anna Shteingauz, et al. · Autophagy · 36
PDF
Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo
2022 · Shiri Davidi, Sara Jacobovitch, et al. · Cancers · 35
PDF
Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin
2014 · Anna Shteingauz, Neta Ilan, et al. · Cellular and Molecular Life Sciences · 34
In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the Torso
2021 · Roni Blatt, Shiri Davidi, et al. · Frontiers in Oncology · 32
PDF
The BTB-MATH protein BATH-42 interacts with RIC-3 to regulate maturation of nicotinic acetylcholine receptors
2009 · Anna Shteingauz, Emiliano Cohen, et al. · Journal of Cell Science · 24
Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP
2013 · Olga Ostrovsky, Avichai Shimoni, et al. · Journal of Leukocyte Biology · 20
Latent Heparanase Facilitates VLA-4–Mediated Melanoma Cell Binding and Emerges As a Relevant Target of Heparin in the Interference with Metastatic Progression
2015 · Ursula Gerber, Sebastian Hoß, et al. · Seminars in Thrombosis and Hemostasis · 11
Alternating electric fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
2016 · Moshe Giladi, Tali Voloshin, et al. · The Journal of Immunology · 8
Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models
2019 · U. Weinberg, N. Kaynan, et al. · Annals of Oncology · 5
Angi-11. Tumor Treating Fields (ttfields) Inhibit Cancer Cell Migration and Invasion by Inducing Reorganization of the Actin Cytoskeleton and Formation of Cell Adhesions
2018 · Rosa S Schneiderman, Moshe Giladi, et al. · Neuro-Oncology · 5
PDF
Abstract 3665: Tumor Treating Fields (TTFields) plus anti-PD-1 therapy induce immunogenic cell death resulting in enhanced antitumor efficacy
2017 · Tali Voloshin, Orna Tal-Yitzhaki, et al. · Cancer Research · 5
Immunomodulatory Effect of Tumor Treating Fields (TTFields) Results in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy in Mouse Model of Lung Cancer
2019 · T. Voloshin, S. Davidi, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959
2023 · Shiri Davidi, Sara Jacobovitch, et al. · Cancers · 2
PDF
Impact of Tumor Treating Fields (TTFields) on DNA Damage Repair in Mesothelioma
2021 · H. Mumblat, A. Martinez-Conde, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and FOLFOX Inhibit Gastric Cancer in Vitro
2019 · E. Zeevi, K. Gotlib, et al. · International Journal of Radiation Oncology*Biology*Physics · 2
PDF
Abstract 3961: Alternating electric fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
2019 · Tali Voloshin, Noa Kaynan, et al. · Immunology · 2
Immu-52. Tumor Treating Fields (ttfields) Induce Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined With Anti-pd-1 Therapy
2018 · Tali Voloshin, Shiri Davidi, et al. · Neuro-Oncology · 2
PDF
Works count: 85
Citation count: 1,389
H-index: 14
I10-index: 15
Year
Topic
Type